---
schema_version: "secwatch.filing_event.v1"
accession: "0001522767-26-000027"
form_type: "8-K"
ticker: "MRMD"
cik: "0001522767"
company_name: "MARIMED INC."
filed_at: "2026-03-11T23:59:59+00:00"
generated_at: "2026-05-15T14:46:12.600365+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# MariMed reports FY2025 revenue of $159.8M, net loss widens to $14.5M, adjusted EBITDA down to $16.9M

## Summary
- FY2025 revenue $159.8M, up from $157.7M in FY2024; Q4 revenue $41.7M vs $38.9M.
- GAAP net loss $14.5M in FY2025 vs $12.4M; Non-GAAP adjusted EBITDA $16.9M, down from $19.3M.
- Wholesale revenue increased 11%; distribution reached 85% of dispensaries in core markets.
- Betty's Eddies ranked #1 edible in MA, MD, DE, IL; restructured Series B debt, extending maturity 4.6 years.
- CEO cites growth drivers for 2026: Delaware adult-use, Maine brand licensing, new Columbus OH dispensary.

## SEC filing metadata
- accession: 0001522767-26-000027
- form_type: 8-K
- ticker: MRMD
- cik: 0001522767
- company_name: MARIMED INC.
- filed_at: 2026-03-11T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1522767/000152276726000027/0001522767-26-000027-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1522767/000152276726000027/mrmd-20260311.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001522767-26-000027
- JSON: https://secwatch.observer/filing/0001522767-26-000027.json
- Plain text: https://secwatch.observer/filing/0001522767-26-000027.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.